3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
16
Carcinoma, Renal Cell
14
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Neoplasms
6
Carcinoma, Medullary
6
Thyroid Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Neuroendocrine Tumors
4
Carcinoma, Transitional Cell
4
Brain Neoplasms
4
Thyroid Cancer, Papillary
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Kidney Neoplasms
3
Adenocarcinoma, Follicular
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Recurrence
2
Pheochromocytoma
2
Paraganglioma
2
Pain
2
Osteosarcoma
2
Multiple Myeloma
2
Interventions
Cyclophosphamide
34
fludarabine
25
fludarabine phosphate
24
Tacrolimus
24
Mycophenolic Acid
23
Whole-Body Irradiation
22
Busulfan
15
Methotrexate
12
Melphalan
12
Granulocyte Colony-Stimulating Factor
12
Antilymphocyte Serum
12
thymoglobulin
11
Cyclosporine
11
Stem Cell Transplantation
10
Filgrastim
10
Rituximab
9
Thiotepa
7
Peripheral Blood Stem Cell Transplantation
7
Nivolumab
7
Dexamethasone
7
trametinib
6
Radiotherapy
6
Mesna
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
Bortezomib
5
Azacitidine
5
Alemtuzumab
5
Voriconazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Neoplasms
×
cabozantinib
×
Clear all
No trials found.